SCHEDULE: PAVmed Inc. Stakeholder Reports 6% Ownership

Craig Kallman and the Craig Kallman 2015 Living Trust jointly report beneficial ownership of 6.0% of PAVmed Inc. common stock.

Summary

• This filing is a Schedule 13G, indicating a passive investment stake.
• Craig Kallman and the Craig Kallman 2015 Living Trust are the reporting persons.
• They collectively beneficially own 384,616 shares of PAVmed Inc. common stock.
• This represents 6.0% of the class of securities outstanding.
• The percentage is based on 6,383,089 shares outstanding as of March 27, 2026.
• Craig Kallman controls the Trust, and may be deemed to beneficially own the shares held by the Trust.
• Both reporting persons have sole voting power and sole dispositive power over these shares.
• A joint filing agreement is in place between Craig Kallman and the Trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports existing ownership stakes without new strategic information or significant changes.

Positives

• Significant passive ownership stake of 6.0% reported by key individuals.
• Clear reporting of sole voting and dispositive power indicates direct control over the shares.

Future Outlook

No forward-looking statements or guidance are provided in this Schedule 13G filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings typically indicate passive investment stakes by institutional investors or insiders, suggesting a lack of intent to influence or control the issuer's management or policies.

Stakeholder Impact

• Shareholders: The filing confirms a significant passive ownership stake, which may be viewed positively as a sign of confidence in the company's long-term prospects, but does not indicate any immediate intent to influence corporate strategy.

Key Dates

Keywords

PAVmed Inc., Schedule 13G, Beneficial Ownership, Craig Kallman, Craig Kallman 2015 Living Trust, Common Stock, SEC Filing, Passive Investment